10 studies found for:    DIAN
Show Display Options
Rank Status Study
1 Recruiting Dominantly Inherited Alzheimer Network (DIAN)
Condition: Alzheimer's Disease
2 Recruiting Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease;   Dementia;   Alzheimers Disease, Familial
Interventions: Drug: Gantenerumab;   Drug: Solanezumab;   Drug: Matching Placebo (Gantenerumab);   Drug: Matching Placebo (Solanezumab)
3 Not yet recruiting A Prospective, Observational, Real-world Study Based on the Register System of Oral and Maxillofacial Malignant Tumors
Conditions: Head and Neck Neoplasms;   Quality of Life;   Postoperative Complications
Interventions: Procedure: resection;   Radiation: adjuvant radiotherapy;   Drug: neoadjuvant chemotherapy or adjuvant chemotherapy
4 Recruiting High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study
Condition: Tuberculosis, Meningeal
Interventions: Drug: Placebo;   Drug: Rifampicin;   Drug: Other TB drugs;   Drug: Adjuvant dexamethasone
5 Completed Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1;   Drug: S-1 plus CDDP;   Drug: 5-FU plus CDDP
6 Active, not recruiting Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
Conditions: Lymphedema;   Musculoskeletal Complications;   Radiation Fibrosis;   Radiation Toxicity;   Sarcoma
Interventions: Drug: chemotherapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
7 Not yet recruiting Efficacy Study of Multiple Micro Nutrients Supplementation
Condition: Anemia, Iron-deficiency
Interventions: Dietary Supplement: Multi-micronutrients;   Dietary Supplement: Maltodextrin and Lactose
8 Recruiting A Phase 1b/2 Study of OMP-59R5 in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: OMP-59R5;   Drug: Gemcitabine;   Drug: Placebo;   Drug: Nab-Paclitaxel
9 Recruiting Quantitative MR Methods for Lipid Emulsions
Condition: Healthy
Intervention: Other: Lipid emulsion
10 Not yet recruiting DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
Condition: Acute NSTEMI
Interventions: Drug: DLBS1033;   Drug: Placebo

Indicates status has not been verified in more than two years